Company Filing History:
Years Active: 2020-2022
Title: Jaume Boix Valverde: Innovator in Bioadhesive Technology
Introduction
Jaume Boix Valverde is a notable inventor based in Spain, recognized for his contributions to the field of bioadhesive technology. His innovative work focuses on developing systems that enhance drug delivery, particularly in the gastrointestinal tract.
Latest Patents
Jaume Boix Valverde holds a patent for a Bioadhesive Platform to Perform Bioactive Treatment. This invention involves compositions that include specific amounts of hyaluronic acid or its pharmaceutically acceptable salts, combined with two thermoreversible adhesive agents, one of which is a poloxamer. The weight ratio between the poloxamer and hyaluronic acid or its salt ranges from 60:1 to 10:1. This platform is designed to serve as a drug delivery system for the local administration of active agents to the gastrointestinal tract. It also encompasses delivery devices that utilize these compositions and their applications in medicine, particularly for treating and preventing mucosal lesions, preventing tumor recurrence, and reducing inflammation in the gastrointestinal tract.
Career Highlights
Throughout his career, Jaume Boix Valverde has worked with esteemed organizations such as Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol and Consorcio Centro de Investigación Biomédica en Red. His work in these institutions has significantly contributed to advancements in biomedical research and innovation.
Collaborations
Jaume has collaborated with notable professionals in his field, including Vicente Maria Lorenzo-Zuniga Garcia and Ramon Bartoli Sole. These collaborations have fostered a productive environment for research and development in bioadhesive technologies.
Conclusion
Jaume Boix Valverde's innovative contributions to bioadhesive technology highlight his commitment to advancing medical treatments. His work continues to influence the field and offers promising solutions for drug delivery systems.